237 related articles for article (PubMed ID: 26400790)
1. Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
Rodrigues ER; Ferreira AG; Leão RS; Leite CC; Carvalho-Assef AP; Albano RM; Marques EA
J Clin Microbiol; 2015 Dec; 53(12):3894-6. PubMed ID: 26400790
[TBL] [Abstract][Full Text] [Related]
2. Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS).
Garrigos T; Neuwirth C; Chapuis A; Bador J; Amoureux L;
Clin Microbiol Infect; 2021 Jan; 27(1):126.e1-126.e5. PubMed ID: 32283265
[TBL] [Abstract][Full Text] [Related]
3. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients.
Garrigos T; Dollat M; Magallon A; Chapuis A; Varin V; Bador J; Makki N; Cremet L; Persyn E; Cardot-Martin E; Echahidi F; Peeters C; Pierard D; Vandamme P; Verroken A; Neuwirth C; Amoureux L
J Clin Microbiol; 2021 Sep; 59(10):e0094621. PubMed ID: 34346714
[No Abstract] [Full Text] [Related]
4. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
[TBL] [Abstract][Full Text] [Related]
5. Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis.
Pereira RH; Leão RS; Carvalho-Assef AP; Albano RM; Rodrigues ER; Firmida MC; Folescu TW; Plotkowski MC; Bernardo VG; Marques EA
Epidemiol Infect; 2017 Feb; 145(3):600-606. PubMed ID: 27873565
[TBL] [Abstract][Full Text] [Related]
6. OXA-258 from Achromobacter ruhlandii: a species-specific marker.
Papalia M; Almuzara M; Cejas D; Traglia G; Ramírez MS; Galanternik L; Vay C; Gutkind G; Radice M
J Clin Microbiol; 2013 May; 51(5):1602-5. PubMed ID: 23467601
[TBL] [Abstract][Full Text] [Related]
7. Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.
Traglia G; Papalia M; Almuzara M; Gutkind G; Centrón D; Vay C; Radice M; Ramírez MS
Curr Microbiol; 2014 Oct; 69(4):501-6. PubMed ID: 24894902
[TBL] [Abstract][Full Text] [Related]
8. Exoproducts of the Most Common
Sahl C; Baumgarten M; Shannon O; Påhlman LI
Microbiol Spectr; 2023 Aug; 11(4):e0019523. PubMed ID: 37284754
[No Abstract] [Full Text] [Related]
9. Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.
Ridderberg W; Wang M; Nørskov-Lauritsen N
J Clin Microbiol; 2012 Aug; 50(8):2688-94. PubMed ID: 22675125
[TBL] [Abstract][Full Text] [Related]
10. Genomic characterization of
Veschetti L; Sandri A; Patuzzo C; Melotti P; Malerba G; Lleo MM
Microb Genom; 2021 Jul; 7(7):. PubMed ID: 34292148
[No Abstract] [Full Text] [Related]
11. Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK.
Coward A; Kenna DT; Perry C; Martin K; Doumith M; Turton JF
J Cyst Fibros; 2016 Jul; 15(4):479-85. PubMed ID: 26412052
[TBL] [Abstract][Full Text] [Related]
12. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin.
Filipic B; Malesevic M; Vasiljevic Z; Lukic J; Novovic K; Kojic M; Jovcic B
Front Cell Infect Microbiol; 2017; 7():224. PubMed ID: 28611955
[No Abstract] [Full Text] [Related]
13. Distribution of
Garrigos T; Dollat M; Magallon A; Folletet A; Bador J; Abid M; Amara M; Beauruelle C; Belmonte O; Boyer P; Cardot-Martin E; Cauchie AG; Colin de Verdière S; Daurel C; Gaudru C; Hamdad F; Héry-Arnaud G; Hoellinger B; Lamoureux C; Lartigue MF; Malandain D; Marchand O; Piau C; Picot S; Revillet H; Sabouni Z; Neuwirth C; Amoureux L
J Clin Microbiol; 2022 Jun; 60(6):e0242221. PubMed ID: 35510500
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.
Barrado L; Brañas P; Orellana MÁ; Martínez MT; García G; Otero JR; Chaves F
J Clin Microbiol; 2013 Jun; 51(6):1927-30. PubMed ID: 23536401
[TBL] [Abstract][Full Text] [Related]
15. Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients.
Rodrigues ER; Rocha GA; Ferreira AG; Leão RS; Albano RM; Marques EA
Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):777-780. PubMed ID: 27812598
[TBL] [Abstract][Full Text] [Related]
16. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
[TBL] [Abstract][Full Text] [Related]
17. Duplex real-time PCR assay for the simultaneous detection of
Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
[TBL] [Abstract][Full Text] [Related]
18. Transmission and Antibiotic Resistance of
Gabrielaite M; Bartell JA; Nørskov-Lauritsen N; Pressler T; Nielsen FC; Johansen HK; Marvig RL
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33472899
[No Abstract] [Full Text] [Related]
19. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.
Spilker T; Vandamme P; Lipuma JJ
J Clin Microbiol; 2012 Sep; 50(9):3010-5. PubMed ID: 22785192
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic applications for the differentiation and species-level identification of achromobacter for clinical diagnoses.
Gomila M; Prince-Manzano C; Svensson-Stadler L; Busquets A; Erhard M; Martínez DL; Lalucat J; Moore ER
PLoS One; 2014; 9(12):e114356. PubMed ID: 25474264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
